Showing results (151-160 of 321) with videos related to

Sort By:
Pageof 33
Psychopharmacology|May 25, 1979
Dimethylaminoethanol (deanol): effect on apomorphine-induced stereotypy and an animal model of tardive dyskinesiaK L Davis, L E Hollister, A L Vento, et al.
Psychopharmacology|January 1, 1981
Alterations in cerebrospinal fluid dopamine metabolites following physostigmine infusionK L Davis, K F Faull, L E Hollister, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 1, 1995
Chronic elevation of secreted amyloid precursor protein in subcortically lesioned rats, and its exacerbation in aged ratsW C Wallace, I Lieberburg, D Schenk, et al.
Biological Psychiatry|March 1, 1987
Platelet [3H]imipramine binding in psychiatric disordersP D Kanof, E F Coccaro, C A Johns, et al.
The American Journal of Psychiatry|August 1, 1988
Growth hormone response to edrophonium in patients with Alzheimer's disease and normal control subjectsM Davidson, B M Davis, L Bastiaens, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|March 11, 2004
A comprehensive analysis of verbal fluency deficit in geriatric schizophreniaC R Bowie, P D Harvey, P J Moriarty, et al.
Biological Psychiatry|January 29, 2000
Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamusS M Richardson-Burns, V Haroutunian, K L Davis, et al.
Neurobiology of Aging|January 1, 1991
Platelet phospholipid synthesis in Alzheimer's diseaseP D Kanof, R C Mohs, J Gross, et al.
Psychopharmacology|January 1, 1991
Effects of indomethacin on plasma homovanillic acid concentration in normal subjects: a study of prostaglandin-dopamine interactionsR S Kahn, M Davidson, P Kanof, et al.
Schizophrenia Research|March 9, 2000
The longitudinal relationship of clinical symptoms, cognitive functioning, and adaptive life in geriatric schizophreniaS R McGurk, P J Moriarty, P D Harvey, et al.
Pageof 33